Crude Omega 3 Market Size, Share, Growth, Industry Analysis, Trends and Dynamics, By Types (Concentrated Fish Oil, Natural Fish Oil), By Applications (Dietary Supplements, Fortified Foods and Beverages, Infant Formula, Drug, Pet Food, Other) , and Regional Insights and Forecast to 2035
- Last Updated: 14-November-2026
- Base Year: 2025
- Historical Data: 2021-2024
- Region: Global
- Format: PDF
- Report ID: GGI105856
- SKU ID: 26043293
- Pages: 103
Download FREE Sample
Crude Omega 3 Market Size
The Global Crude Omega 3 Market was valued at USD 753.91 Million in 2025, is expected to reach USD 799.14 Million in 2026 and USD 847.09 Million in 2027, and is projected to touch USD 1350.14 Million by 2035, growing at a CAGR of 6% over the forecast period from 2026 to 2035.
Growth in the Crude Omega 3 Market is steady rather than speculative. It rests on repeat consumption, expanding clinical interest in EPA and DHA, and wider use of marine oils in food and feed. About 46% of volume demand flows into dietary supplements, while concentrated grades account for nearly 62% of type-level purchasing. Manufacturers that secure fresh raw material and refine it with tight oxidation control are best placed to benefit.
![]()
In the US Crude Omega 3 Market, demand is anchored by a mature supplement culture, where roughly 1 in 3 adults reports using a dietary supplement that contains marine omega 3. Concentrated grades make up about 66% of regional type demand, and contract manufacturers account for nearly 40% of local oil procurement.
The Crude Omega 3 Market is expanding on the back of repeat consumption rather than short-lived demand spikes. Dietary supplements absorb approximately 46% of total volume, and concentrated grades account for nearly 62% of type-level purchasing, which shows how strongly buyers value potency and purity.
Key Findings
- Starting at USD 799.14 Million in 2026, the global Crude Omega 3 Market is set to witness steady growth, reaching USD 847.09 Million in 2027 and projected to reach USD 1350.14 Million by 2035. The market is expected to expand at a CAGR of 6% throughout the forecast period from 2026 to 2035.
- Demand for crude omega 3 is increasing due to expanding use across dietary supplements, fortified foods and beverages, infant formula, pharmaceutical formulations, and premium pet nutrition. Dietary supplements account for approximately 46% of overall market demand, supported by consistent consumer interest in heart health, cognitive function, and eye health, along with strong repeat purchasing behavior.
- Crude omega 3 plays an important role in the marine nutrition value chain by serving as the starting material for refining, concentration, and encapsulation into finished EPA and DHA products. Concentrated Fish Oil represents approximately 62% of type-level demand, while Natural Fish Oil accounts for nearly 38% as buyers balance potency requirements against processing cost and formulation flexibility.
- Growth in clinical nutrition, infant formula fortification, and pharmaceutical-grade oil programs is accelerating demand for higher-purity feedstock. Approximately 23% of application demand is linked to infant formula and drug uses, while nearly 58% of institutional buyers treat traceability and oxidation control as essential supplier qualification criteria.
- Asia-Pacific accounts for approximately 34% of the global Crude Omega 3 Market, supported by large marine processing capacity and rising supplement adoption. Europe represents about 29%, North America holds nearly 27%, and Middle East & Africa contributes close to 10% as quality standards, sustainability expectations, and consumer health awareness shape regional demand.
Crude Omega 3 Market demand is built on a stable consumption base. Nearly 63% of supplement buyers who start omega 3 products continue them, which gives upstream oil suppliers a steady order book. Procurement planning increasingly shifts toward longer supply agreements, since about 36% of buyers say raw material continuity matters more than short-term price movement.
Competition is also being shaped by quality differentiation. About 52% of new product programs specify tighter peroxide and anisidine limits than regulatory minimums, which favors producers with controlled processing, nitrogen blanketing, and rapid cold-chain handling. Suppliers that can document these practices tend to win larger and more repeatable contracts.
![]()
Crude Omega 3 Market Trends
The most visible trend in the Crude Omega 3 Market is the move toward higher potency and cleaner sensory profiles. Brands are reformulating around smaller softgels and fewer capsules per serving, which raises demand for oils with higher EPA and DHA density. Approximately 57% of new supplement launches now highlight concentration, purity, or reduced aftertaste as a lead claim. This pushes crude oil suppliers to deliver cleaner starting material with lower free fatty acid content, since better feedstock reduces refining losses and improves finished product consistency.
A second trend is the growing weight of traceability and sustainability in sourcing decisions. Nearly 44% of buyers now request batch-level documentation covering species, catch region, and processing conditions, and about 31% prefer suppliers with certified fishery sourcing. At the same time, producers are investing in faster on-vessel and dockside processing to limit oxidation before the oil reaches refining plants. Digital quality tracking, tighter cold-chain handling, and diversification across anchovy, sardine, and mackerel feedstocks are becoming standard practice for suppliers that want to hold premium contracts and reduce exposure to single-species volatility.
Crude Omega 3 Market Dynamics
Growth in pharmaceutical-grade and clinical nutrition applications
Significant opportunity exists in higher-value uses where oil quality is the main purchasing criterion. Drug and infant formula applications together account for approximately 23% of application demand, yet their share can widen as clinical research links EPA and DHA to cardiovascular, cognitive, and developmental outcomes. Nearly 39% of ingredient developers say they are exploring higher-purity concentrates for medical nutrition and specialty formulations. Suppliers that can offer low-oxidation, well-characterized oils with stable specifications can move away from commodity pricing and build longer relationships with regulated buyers. Opportunities also arise in pet nutrition, where about 8% of demand is growing alongside premium pet food formulation.
Rising consumer focus on heart, brain, and preventive health
The principal growth driver is the global shift toward preventive nutrition. Dietary supplements account for approximately 46% of total consumption, and cardiovascular and cognitive support remain the two most cited reasons for purchase. Nearly 34% of health-conscious consumers say they take omega 3 daily rather than occasionally, which supports steady upstream oil demand. Fortified foods and beverages add another 17% of demand as manufacturers add EPA and DHA to dairy, bakery, and drink products. These conditions favor suppliers capable of providing consistent oil quality, controlled oxidation, and dependable delivery schedules to large formulators and contract manufacturers.
| Market Driver | Impact Rank | Contribution | 2026-2028 | 2029-2031 | 2032-2035 |
|---|---|---|---|---|---|
| Rising consumption of dietary supplements for heart, brain, and eye health | High | 3.1% | High | High | Medium |
| Expanding use of concentrated EPA and DHA in pharmaceutical and clinical nutrition | High | 2.4% | High | High | Medium |
| Growth of fortified foods, infant formula, and premium pet nutrition | Medium | 1.7% | Medium | High | Medium |
| Improved refining technology and traceable marine ingredient supply chains | Medium | 1.2% | Medium | Medium | Medium |
| Rising health awareness across emerging Asia-Pacific and Middle East populations | Low | 0.5% | Medium | Medium | Low |
| Others | Lowest | 0.3% | Low | Low | Low |
| Total Driver Contribution | 9.2% |
RESTRAINTS
"Raw material volatility and sourcing uncertainty"
The Crude Omega 3 Market remains dependent on wild-caught small pelagic fish, whose availability shifts with climate patterns, quota decisions, and seasonal biomass. In weaker catch periods, oil supply can tighten by as much as 20% in affected producing regions, which quickly raises procurement costs for refiners and brands. Nearly 37% of buyers report that supply interruptions have forced them to qualify alternative origins on short notice. Smaller processors feel the pressure most, since they have limited ability to hedge raw material exposure. Competing demand from fishmeal and aquafeed producers adds further tension, because the same fish stocks serve several industries at once.
| Market Restraint | Impact Rank | Negative CAGR Impact | 2026-2028 | 2029-2031 | 2032-2035 |
|---|---|---|---|---|---|
| Volatility in fish catch quotas and raw material availability | High | -1.5% | High | High | Medium |
| Sustainability scrutiny and rising regulatory compliance cost | Medium | -1.0% | Medium | Medium | Medium |
| Competition from algal and plant-based omega 3 alternatives | Low | -0.5% | Low | Medium | Medium |
| Others | Lowest | -0.2% | Low | Low | Low |
| Total Restraint Impact | -3.2% |
CHALLENGE
"Maintaining oxidation control and consistent quality"
Omega 3 oils are chemically delicate, and quality losses can occur at any point from catch to delivery. Approximately 29% of quality complaints in marine oil trade are linked to oxidation, rancidity, or odor deviations that appear after storage or transport. Meeting tighter customer specifications requires investment in rapid processing, inert gas handling, and temperature-controlled logistics, which can add 8% to 12% to handling effort for smaller operators. Differences in testing methods between regions can also create disputes over acceptance criteria. Producers that cannot demonstrate stable batch performance risk losing long-term contracts to better-equipped competitors.
Segmentation Analysis
Segmentation in the Crude Omega 3 Market reflects how buyers balance potency, processing intensity, and end-use requirements. Type-based demand divides between concentrated and natural grades, with concentration level shaping price positioning and formulation flexibility. Application demand is far more diversified, spanning supplements, food fortification, infant nutrition, pharmaceuticals, and animal nutrition. Roughly 62% of volume moves in concentrated form, while about 46% of consumption is absorbed by a single application, which shows both the depth of supplement demand and the growing importance of specialized end markets.
By Type
Concentrated Fish Oil
Concentrated Fish Oil accounts for approximately 62% of type-level demand, driven by brands seeking higher EPA and DHA content per capsule and cleaner sensory performance. About 49% of new product launches in this category specify concentrations above standard natural oil levels. Pharmaceutical and clinical nutrition buyers prefer this grade because dosing precision and purity are easier to document. Processing costs are higher, but the premium is accepted where potency, reduced pill burden, and stable specifications matter more to the customer than the lowest unit price.
Natural Fish Oil
Natural Fish Oil holds nearly 38% of type-level demand and appeals to buyers who value a minimally altered fatty acid profile and simpler processing. Approximately 41% of food fortification and pet nutrition users prefer natural grades because they are easier to blend and carry lower cost. Demand is stable in regions where price sensitivity is high and where consumers favor products described as closer to the original source. Quality management and freshness remain the central competitive factors for suppliers in this category.
By Application
Dietary Supplements
Dietary Supplements are the largest application, representing approximately 46% of total demand. Softgel capsules, liquids, and gummies all rely on a steady supply of refined marine oil, and about 58% of regular users cite heart health as their primary purchase reason. Product innovation around smaller capsules and flavored formats is raising demand for higher-potency feedstock. Retail and online channels together support consistent reorder rates, which gives suppliers reliable volume visibility compared with more cyclical applications.
Fortified Foods and Beverages
Fortified Foods and Beverages contribute close to 17% of application demand. Dairy products, bakery items, juices, and nutrition bars are the main carriers, and approximately 33% of new fortified launches now include omega 3 as a headline nutrient. The segment requires oils with low odor and good oxidative stability, since taste defects can quickly damage consumer acceptance. Encapsulated and emulsified delivery systems are helping manufacturers widen the range of products that can carry marine oils.
Infant Formula
Infant Formula represents about 12% of application demand and operates under some of the strictest quality expectations in the market. Roughly 70% of premium formula products include DHA, which keeps demand resilient across economic cycles. Buyers in this category demand extensive purity testing, contaminant control, and stable supply documentation. Qualification periods are long, but once suppliers are approved, volumes tend to be steady and contracts are often multi-year in nature.
Drug
Drug applications account for nearly 11% of demand and rely on concentrated, highly purified oils meeting pharmaceutical specifications. About 27% of ingredient developers working with prescription-grade omega 3 are exploring improved formulations and delivery formats. Regulatory scrutiny is high, so supplier audits and documentation requirements are extensive. Although the segment is smaller in volume, it supports premium pricing and strengthens the technical reputation of suppliers that serve it successfully.
Pet Food
Pet Food holds roughly 8% of application demand, supported by premiumization in dog and cat nutrition. Approximately 45% of owners buying premium pet products say skin, coat, and joint support influence their choice, and omega 3 is a common formulation answer. Manufacturers often accept natural grades in this segment, which keeps cost in check while maintaining functional claims. Growth is steady as pet humanization spreads into emerging markets.
Other
Other applications make up close to 6% of demand and include aquaculture feed additives, cosmetic ingredients, and specialized clinical products. About 22% of this group is linked to aquafeed formulations that use marine oils to improve fish growth and fillet quality. Cosmetic and personal care uses are small but growing as brands add marine lipids to skin care formulations. These niches add diversification and help suppliers manage exposure to supplement demand cycles.
![]()
Crude Omega 3 Market Regional Outlook
The regional picture of the Crude Omega 3 Market combines producing regions with strong consumption centers. Asia-Pacific leads with approximately 34% of the global market, followed by Europe with 29%, North America with 27%, and Middle East & Africa with 10%. Raw material origin, refining capacity, and consumer purchasing power differ sharply between these regions, so trade flows move crude and refined oil across borders. Regions that combine local refining with strong brand ecosystems tend to capture more value from each ton of oil.
North America
North America accounts for approximately 27% of the global market, supported by a mature supplement culture and strong contract manufacturing infrastructure. Concentrated grades represent about 66% of regional oil demand, reflecting consumer preference for higher-potency products. Nearly 38% of regional purchasing is driven by e-commerce and direct-to-consumer brands. Buyers place heavy weight on purity testing and label accuracy, which supports suppliers able to document oxidation values and contaminant levels for each shipment.
Europe
Europe holds close to 29% of the global market and has one of the most quality-conscious buyer bases. Regulatory expectations around contaminants, labeling, and sustainability are demanding, and about 52% of regional buyers require traceable fishery sourcing. Pharmaceutical and infant nutrition applications together represent roughly 25% of regional demand, which is above the global average. Established refining capacity in Northern and Western Europe supports local production of high-purity concentrates for export as well as domestic use.
Asia-Pacific
Asia-Pacific leads with approximately 34% of the global market, combining large consumer populations with extensive marine processing capacity. Fortified foods and infant formula account for nearly 33% of regional demand, a higher share than in most other regions. Rising incomes and aging populations are lifting supplement adoption, with about 41% of urban consumers in major markets reporting regular nutritional supplement use. Local producers are upgrading refining technology to move from crude exports toward higher-value concentrated products.
Middle East & Africa
Middle East & Africa represents about 10% of the global market and is the smallest but one of the faster-evolving regions. Approximately 60% of regional supply is imported as refined or encapsulated products, reflecting limited local refining capacity. Health awareness around cardiovascular disease and diabetes is lifting supplement use, particularly in Gulf countries, where premium retail channels are expanding. Infant nutrition and pharmaceutical distribution networks are building capacity, which creates entry points for international suppliers over time.
List of Key Crude Omega 3 Market Companies Profiled
- DSM
- BASF
- Pelagia (EPAX)
- Golden Omega
- TASA
- Omega Protein
- Croda
- GC Rieber
- Polaris
- Yuwang
- Auqi
- Kinomega
- Skuny
- Xinzhou
- Renpu Pharmaceuticals
- Sinomega
Top Companies with Highest Market Share
- DSM: Holds approximately 14% of the global market, supported by a broad concentrated omega 3 portfolio and strong ties with supplement and infant nutrition customers.
- BASF: Accounts for nearly 11% of the global market, backed by integrated refining capability and a strong position in pharmaceutical-grade oils.
Investment Analysis and Opportunities
Investment activity in the Crude Omega 3 Market is concentrating on refining upgrades, cold-chain logistics, and traceability systems rather than on raw volume expansion alone. Approximately 46% of announced capital programs focus on concentration and purification equipment, because higher-value grades offer better margin stability. Nearly 28% of spending is directed toward sustainability and fishery certification, as buyers increasingly make these credentials a condition for entering contracts. Regional processors in Asia-Pacific and Latin America are attracting investors by showing improvements in yield, with some plants reporting gains of 10% to 15% in oil recovery after process upgrades. Partnerships between refiners and consumer brands are also growing, with about 34% of new supply agreements including multi-year volume commitments. Opportunities are strongest for producers that combine raw material security, documented quality, and the ability to serve both supplement and pharmaceutical customers from the same operating base.
New Products Development
New product development in the Crude Omega 3 Market is centered on potency, taste, and stability. Roughly 54% of recent launches emphasize higher EPA and DHA concentration, while about 36% focus on improved oxidative stability through advanced antioxidant systems and inert handling methods. Manufacturers are also developing oils tailored to specific uses, such as low-odor grades for fortified beverages and high-purity concentrates for clinical nutrition. Nearly 31% of development programs now target specialized ratios of EPA to DHA for cognitive, cardiovascular, or maternal health positioning. Encapsulation technologies, including emulsions and powdered oil formats, are expanding the range of food and beverage carriers that can use marine oils without sensory penalties. Suppliers that pair these product innovations with transparent analytical documentation are gaining preference among large formulators.
Recent Developments
- March 2024– DSM expands concentrated omega 3 refining capability: The company increased refining and concentration throughput for high-potency marine oils, raising processing efficiency by roughly 12%. The move supports growing demand from supplement and infant nutrition customers who need consistent EPA and DHA density.
- June 2024– BASF strengthens pharmaceutical-grade omega 3 supply: BASF broadened its high-purity oil offerings for clinical and prescription applications, with about 15% of its marine lipid portfolio now aligned to pharmaceutical specifications. This reinforces its position among regulated buyers.
- September 2024– Golden Omega improves raw material traceability: The company introduced batch-level documentation covering species and catch region across nearly 80% of its output. The program responds to rising buyer demand for verifiable sourcing and tighter quality records.
- February 2025– Croda advances specialty marine lipid formulations: Croda focused on specialty lipid grades for nutrition and personal care, with close to 20% of recent development effort directed at higher-stability formulations. The initiative widens its reach into premium nutritional applications.
- July 2025– TASA upgrades processing for oxidation control: TASA invested in faster processing and improved storage handling, aiming to cut oxidation-related quality deviations by about 18%. The upgrade supports delivery of fresher crude oil to downstream refiners and strengthens its position in export markets.
Report Coverage
The report covers the Crude Omega 3 Market across type, application, and regional dimensions, including Concentrated Fish Oil and Natural Fish Oil, as well as Dietary Supplements, Fortified Foods and Beverages, Infant Formula, Drug, Pet Food, and Other uses. It reviews competitive positioning among leading suppliers, supply chain structure, pricing behavior, regulatory influences, and technology direction. Regional analysis examines North America, Europe, Asia-Pacific, and Middle East & Africa, with attention to production strength, consumption patterns, and trade flows. Approximately 62% of the analysis focus relates to quality and processing dynamics that shape supplier selection.
The SWOT analysis highlights clear strengths in established health credentials, broad application reach, and loyal repeat consumption, with supplements anchoring nearly half of total demand. Weaknesses include dependence on wild fish stocks and sensitivity to oxidation during handling. Opportunities arise from clinical nutrition, premium pet food, and emerging regions where awareness is still developing. Threats include algal and plant-based alternatives, stricter sustainability rules, and climate-linked fluctuations in catch volumes that can quickly tighten supply.
Future Scope
The future of the Crude Omega 3 Market points toward higher-value, better-documented, and more diversified supply. Concentrated grades, already near 62% of type-level demand, are expected to gain further share as brands pursue smaller dosage formats and cleaner taste profiles. Pharmaceutical and clinical nutrition applications, which currently represent about 11% of demand, should expand as research strengthens links between EPA and DHA and long-term health outcomes. Emerging markets in Asia-Pacific and the Middle East will remain important growth areas, supported by rising incomes and greater health awareness. Sustainability will move from a differentiator to a baseline expectation, with nearly half of institutional buyers likely to require certified sourcing. Investments in traceability, refining efficiency, and alternative feedstock blending should help suppliers manage raw material risk while meeting stricter quality and environmental standards.
Crude Omega 3 Market Report Coverage
| REPORT COVERAGE | DETAILS | |
|---|---|---|
|
Market Size Value In |
USD 799.14 Million in 2026 |
|
|
Market Size Value By |
USD 1350.14 Million by 2035 |
|
|
Growth Rate |
CAGR of 6% from 2026 - 2035 |
|
|
Forecast Period |
2026 - 2035 |
|
|
Base Year |
2025 |
|
|
Historical Data Available |
Yes |
|
|
Regional Scope |
Global |
|
|
Segments Covered |
By Type :
By Application :
|
|
|
To Understand the Detailed Market Report Scope & Segmentation |
||
Download FREE Sample
Frequently Asked Questions
-
What value is the Crude Omega 3 Market expected to touch by 2035?
The global Crude Omega 3 Market is expected to reach USD 1350.14 Million by 2035.
-
What CAGR is the Crude Omega 3 Market expected to exhibit by 2035?
The Crude Omega 3 Market is expected to exhibit a CAGR of 6% by 2035.
-
Who are the top players in the Crude Omega 3 Market?
DSM, BASF, Pelagia (EPAX), Golden Omega, TASA, Omega Protein, Croda, GC Rieber, Polaris, Yuwang, Auqi, Kinomega, Skuny, Xinzhou, Renpu Pharmaceuticals, Sinomega
-
What was the value of the Crude Omega 3 Market in 2025?
In 2025, the Crude Omega 3 Market value stood at USD 753.91 Million.
About the Author(s):
This report was authored by the Healthcare Research Team at Global Growth Insights. The team specializes in pharmaceuticals, biotechnology, medical devices, diagnostics, digital health, healthcare services, and life sciences. Their expertise includes market sizing, regulatory analysis, competitive benchmarking, and healthcare trend forecasting to support strategic investment and business growth.
Our Clients
Download FREE Sample